Global Market Study on Transcatheter Heart Valve Replacement and Repair: High Demand For Minimally Invasive Surgeries in Aortic Stenosis Cases to Drive the Market for THVR During the Forecast Period


  • Published On : Jun-2016 |
  • Pages : 164 Pages |
  • Format :

REPORT DESCRIPTION

This Persistence Market Research (PMR) report examines the ‘Global Transcatheter Heart Valve Replacement & Repair Market’ for the period 2016–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global transcatheter heart valve replacement & repair market.

The primary objective of the report is to offer insights into developments in the transcatheter heart valve device market that are transforming related global businesses and enterprises. The primary factors fuelling adoption of transcatheter heart valve devices are growing demand for transcatheter bioprosthetic valve implants among geriatric population that are considered high risk patients for conventional open heart surgery. Moreover, increasing prevalence of valvular heart disease among aging population, rising number of transcatheter valve implant procedures worldwide, and favorable reimbursement policies are some other factors expected to fuel growth of global market over the following five years. Availability of highly developed and technically advanced medical device manufacturing infrastructure in Europe and North America, makes them major markets for transcatheter heart valve products.

The transcatheter heart valve replacement & repair market report begins by defining the product type, surgical approach and end users. It is followed by an overview of the market dynamics of the global market, which includes PMR’s analysis of key trends, drivers, restraints, opportunities, regulations and government initiatives, which are influencing growth of the global transcatheter heart valve replacement & repair market. Impact analysis on key growth drivers and restraints based on the weighted average model has also been included in this report after analysis of individual regions. This would better equip readers with meaningful insights on the ongoing activities in the market. At the end of the report, PMR has provided an exclusive section on key strategic considerations for a new entrant planning to enter the transcatheter heart valve replacement & repair market in the near future. The section highlights key requirements, which should be used to assess the quality of bioprosthetic heart valves produced, to better capture higher market share and emerge sustainably profitable over the long term.

The global transcatheter heart valve replacement & repair market is analyzed by segmenting it on the basis of product type, surgical approach and end user. On the basis of product type, the market has been segmented into transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). By surgical approach, the market has been segmented into transfemoral approach, transapical approach and transaortic approach. On the basis of end user, the market has been segmented into hospitals, ambulatory surgical centers and cardiac catheterization laboratory. A detailed analysis of every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index, and BPS analysis has been provided along with appropriate rationale.

The following section of the report highlights growth trends witnessed in the transcatheter heart valve replacement & repair market. It provides a market outlook for 2016–2026 and sets the forecast within the context of the transcatheter heart valve replacement & repair market. The study discusses key trends contributing to growth of the transcatheter heart valve replacement & repair market worldwide and also analyses the extent to which the corresponding drivers influence this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and sMEA.

Analysis by product type, implantable approach, end users and regions helps in evaluating the present scenario and growth prospects of the transcatheter heart valve replacement & repair market for the period 2016 –2026. We have considered 2015 as the base year and provided data for the forecast period.

To ascertain the transcatheter heart valve replacement & repair market size, we have also considered key quality assessment parameters that should be considered while judging the quality and grading of bioprosthetic heart valves. The forecast presented here assesses the total revenue generated across the transcatheter heart valve replacement & repair market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the transcatheter heart valve replacement & repair market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of the three different types of analysis, based on supply side, downstream industry demand, and the economic envelope.

It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse the market on the basis of key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities in the transcatheter heart valve replacement & repair market.

The transcatheter heart valve replacement & repair segments have been analysed in terms of basis point share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the transcatheter heart valve replacement & repair market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective, in the transcatheter heart valve replacement & repair market.

To understand key growth areas of transcatheter heart valve replacement & repair in the near future, Persistence Market Research developed the transcatheter heart valve replacement & repair market’s ‘Attractiveness Index’, which has been represented by for all four categories, PRODUCT type, implantable approach, end users and regions. The resulting index is expected to help providers identify real market opportunities.

In the final section of the report, information related to the transcatheter heart valve replacement & repair ‘Strategic Recommendation’ is included to provide report companies with insights required while entering a specific segment or a country to strengthen their revenue footprints in the transcatheter heart valve replacement & repair market and to differentiate themselves. Key categories of providers covered in the report are transcatheter heart valve replacement & repair manufacturers. Detailed company profiles have been primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a key market segment in the transcatheter heart valve replacement & repair value chain and the potential players with respect to the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the transcatheter heart valve replacement & repair market.

Detailed profiles of the providers also include company-specific long- and short-term strategies, key offerings, and recent developments in the transcatheter heart valve replacement & repair market. Key competitors in the market include Edwards Lifesciences Corporation, Medtronic, Inc., Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Inc., St. Jude Medical, Inc., JenaValve Technology, SYMETIS, Braile Biomedica.

Key Segments Covered

By Product Type

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Repair (TMVR)

By Surgical Approach

  • Transfemoral Approach
  • Transapical Approach
  • Transaortic Approach

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratory

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East & Africa

Key Companies

  • Edwards Lifesciences Corporation
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Jude Medical, Inc.
  • JenaValve Technology
  • SYMETIS
  • Braile Biomedica

Transcatheter heart valve implantation is a procedure with less invasive approach helps in replacing the heart valve with prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. It is the effective alternative to cumbersome open heart surgery especially for high risk patients. The procedure helps reduce severe degenerative aortic stenosis and increases survival rate of patients. Increasing percutaneous transcatheter prosthetic valve implantation worldwide is expected to drive demand for transcatheter heart valve devices, as risk of valvular heart disease is higher among geriatric population, owing to increasing prevalence of severe aortic stenosis and asymptomatic severe mitral regurgitation.

The global transcatheter heart valve replacement & repair market was valued at US$ 1,605.5 Mn in 2015 and is expected to expand at a CAGR of 13.9% over the forecast period (2016–2026).

Drivers and Trends

The prime driver for the transcatheter heart valve replacement & repair market is rising demand for less invasive procedure for high risk patients, growing prevalence of mitral regurgitation and severe aortic stenosis disorder. Moreover, shorter recovery time, less stay in the hospitals, favorable outcomes with transcatheter prosthetic valve implantation and technological advancements are also driving adoption of transcatheter heart valve devices. However, high costs of transcatheter heart valves, risk associated with procedure and certain device related issue such as product recalls by manufacturers, malpositioning during implantation impede growth of the market to a certain extent.

Market Segmentation by Product Type

On the basis of product type, the market has been segmented into transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). In terms of value, TAVR segment is expected to account for 79.9% market share in global transcatheter heart valve replacement & repair market by 2026 end.

Market Segmentation by Surgical Approach

On the basis of surgical approach, the market has been segmented into transfemoral approach, transapical approach and transaortic approach. Transfemoral segment accounted for highest market share of 82.1% in 2015 and is expected to retain its dominance throughout the forecast period. Increasing focus on investigational products by various vendors boost the market growth of transcatheter valves across the globe.

Market Segmentation by End User

On the basis of end user, the market has been segmented into hospitals, ambulatory surgical centres and cardiac catheterization laboratory. Hospital segment is expected to exhibit the highest growth over the forecast period, followed by cardiac catheterization laboratory segment. Increasing patient population seeking effective and efficient treatment with shorter recovery time are key factors driving adoption of new medical devices and technologies in hospitals.

Key Regions

The global transcatheter heart valve replacement & repair market has been segmented into five major regions namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa (MEA). In terms of value, the North America market is estimated to dominate the global transcatheter heart valve replacement & repair market in 2016, and is expected to expand at a CAGR of 14.2% over the forecast period. Asia Pacific excluding Japan, MEA, and Latin America are expected to be the fastest growing markets over the forecast period. Asia Pacific excluding Japan market is expected to witness highest CAGR of 13.9 % over the forecast period. In North America, segment is expected to grow at faster rate to reach the value US$ 3,552.4 Mn by 2026 end. Market in Europe is expected to exhibit healthy CAGR owing to growing acceptance of THV products in the region.

Key Players

Some of the key players in the global transcatheter heart valve replacement & repair market are Edwards Lifesciences Corporation, Medtronic, Inc., Boston Scientific Corporation, Abbott Laboratories, St. Jude Medical, Inc., St. Jude Medical, Inc., JenaValve Technology, SYMETIS, Braile Biomedica.

Company Profiles

  • Edwards LifeSciences Corporation
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • St. Jude Medical, Inc. 
  • JenaValve Technology
  • SYMETIS
  • Braile Biomedica 
  • other
Back To Top